War on drug prices: The Tipline for 9 April 2019
A Republican congressman has put forward legislation that would allow private health insurance issuers to jointly negotiate wholesale acquisition prices of prescription drugs with antitrust immunity. The bill, which aims to tackle sky-high pharmaceutical prices, appears to have no cosponsors so far. Meanwhile, the Department of Justice is continuing its fight against construction bid-rigging, moving on from flooring to insulation. This could become like the sprawling auto parts cartel prosecution, where it eventually was easier to name parts of the car that hadn’t been price-fixed.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10